Tumor targeting with docosahexaenoic acid-conjugated docetaxel for inhibiting lung cancer metastasis to bone

Docetaxel (DTX) is currently used as a first- or second-line drug treatment for patients with lung cancer, however, it is less effective for the treatment of patients with bone metastasis of lung cancer. This is primarily due to the fact that docetaxel is nonspecific. In the present study, docosahex...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shougang, Liu, Zhiguo, Wu, Lei, Yuan, Yingjie, Hu, Yan, Zhang, Xingyao, Wei, Liang, Zu, Yuangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096075/
https://www.ncbi.nlm.nih.gov/pubmed/30127879
http://dx.doi.org/10.3892/ol.2018.9047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096075/
https://www.ncbi.nlm.nih.gov/pubmed/30127879
http://dx.doi.org/10.3892/ol.2018.9047

Ejemplares similares